The B.C. court rules investor was “contributorily negligent”
Canaccord’s research team now includes nine senior healthcare analysts across three continents
Counterclaim for damages headed to trial
The firm will also be added to two other S&P/TSX indices
Court rules Canaccord made best efforts to accommodate IIROC restrictions imposed on advisor switching firms
New head of U.S. fixed income sales hired
Alexis de Rosnay to replace Mark Brown
IIROC panel finds two Canaccord Genuity reps solicited investments in a private placement without the knowledge of their firm
Departing COO played a significant role in the development of the firm
Wealth manager partners with Fi360 Canada to offer Accredited Investment Fiduciary Professional designation training